Vifor Pharma has been acquired by CSL Behring and is now branded CSL Vifor. It aims to become the leader in iron deficiency, nephrology and cardio-renal therapies. The company strives to help patients around the world with severe and chronic diseases lead better, healthier lives.

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
  • Number of employees in Switzerland

You may also be interested in